Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019)

Avantor's (AVTR) quarterly Net Equity Issued and Repurchased came in at -$100000.0 in Q3 2019, down 100.0% quarter-over-quarter from $3.0 billion in Q4 2017.

Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019) Analysis & Trends

Avantor's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$100000.0 for Q3 2019.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$100000.0 in Q3 2019; TTM through Dec 2020 was -$100000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $967.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased declined to -$100000.0 in Q3 2019 per AVTR's latest filing, from $3.0 billion in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $3.0 billion in Q4 2017 and bottomed at -$100000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 7.43 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 11.72 Mn
10 Avantor 7.67 Bn 7.39 Bn 500.70 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -100,000.00
Sep 30, 2019 -100,000.00
Dec 31, 2017 3.05 Bn
Dec 31, 2017 3.05 Bn